Pharma Faces: Demet Russ, Janssen Turkey
After an international career spanning 25 years, Demet Russ returned to her native Turkey to lead the Janssen affiliate during a tumultuous time and is aiming to give back to…
Keymen Pharmaceuticals established in 1973 with Keymen Ecza Depoculuk ve Ticaret Ltd. Sti. name and operates under DMT Group.
Foundation of DMT group began with the establishment of Dr.Mustafa Topal’s first personal firm in 1965 and with establishment of Ecz.Perihan Topal Import-Export-Representation firm in 1970. Starting inn 1966, the firm handled the importation & distribution of special medicines of Dr.Anna Arslan from Romaina and medical equipment from USSR. During visits to East European countries, Dr.Mustafa Topal saw that high attention was given to public health services, and that products for public health in this region were very cheap. After investigating public health products further, Keyman began to cooperate with the Institute of Immunology and Virology Torlak in Belgrade, Serbia, and the Institute of Immunology Inc in Zagreb, Croatia, for the sales of vaccines and antisera in Turkey, collaboration that continue today.
Contact Details
Keymen İlaç Sanayi ve Ticaret A.Ş.
Şehit Gaffar Okkan Cad. No: 40
Gölbaşı 06830 ANKARA
Tel: 0 312 485 37 60
Fax: 0 312485 37 61
Keymen İlaç Sanayi ve Ticaret A.Ş.
Çamlık Mah. İkbal Cad. Dinç Sok. No:25
Ümraniye İSTANBUL
Tel: 0216 415 03 30
Fax: 0 216 415 03 27
After an international career spanning 25 years, Demet Russ returned to her native Turkey to lead the Janssen affiliate during a tumultuous time and is aiming to give back to…
Avinash Potnis of Novartis Turkey discusses potential solutions to the country’s access and pricing dilemma which has raised concerns of system sustainability. Potnis also highlights the strengths of Turkey’s healthcare…
Ingrid Drechsel, head of Bayer’s pharma operations in Turkey and Iran, discusses the complexity of managing two countries under economic pressure and the advantages of Bayer’s longstanding relationship in both…
Menarini’s general manager for Turkey, the Middle East and Africa Uğur Bingöl discusses the Italian company’s restructuring in the region and its desire to replicate its success in Turkey across…
The secretary general for Turkey’s Pharmaceutical Manufacturers Association (IEIS), Savaş Malkoç, highlights their objective of increasing R&D expenditure and Turkey’s big opportunity ahead in biosimilars production. In addition, Malkoç discusses…
Janssen’s Managing Director for Turkey, Demet Russ, discusses her return to the country after 25 years abroad, having worked for Johnson & Johnson in different local, regional and global roles…
As one of the leading pharma companies in Turkey, DEVA is pioneering a new approach to generics in the country. Chairman of the Board and CEO Philipp Haas discusses the…
As COVID-19 began spreading through the world, the race to understand the disease by scientists and doctors took off. After just a few months, it became apparent that people with…
The president of the Turkish Society of Cardiology, Mustafa Kemal Erol, discusses the prevalence of cardiovascular disease, which accounts for over a third of deaths in Turkey, the improvements made…
AmCham Turkey’s executive director, Asli Özelli, examines the impact of US companies on the Turkish economy with over USD 50 billion in investment, their help during the pandemic, the chamber’s…
Dr Burak Cem, Novo Nordisk Vice President and General Manager for Turkey, outlines the company’s big bet on Turkey as a future regional hub through deep investment in clinical trials,…
Turkey’s former Minister of Health, Bülent Akarcali, outlines the country’s healthcare system evolution over the past decades, comparing the improvements to the difference between a Ford Model T to a…
See our Cookie Privacy Policy Here
